Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
3,109 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00339196 | 5-azacytidine Valproic Acid and ATRA in AML and High Risk MDS | completed | Phase 2 | 25 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 9, 2011 | clinicaltrials |
| NCT00006112 | Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer | unknown | Phase 2 | — | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Apr 26, 2011 | clinicaltrials |
| NCT00371345 | Study of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast Cancer | completed | Phase 2 | 92 | Bristol-Myers SquibbINDUSTRY | 7 | Apr 26, 2011 | clinicaltrials |
| NCT00174343 | Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients | completed | Phase 2 | 46 | PfizerINDUSTRY | 1 | Apr 22, 2011 | clinicaltrials |
| NCT00101647 | Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia | completed | Phase 2 | 197 | Bristol-Myers SquibbINDUSTRY | 23 | Apr 15, 2011 | clinicaltrials |
| NCT00101595 | Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia | completed | Phase 2 | 96 | Bristol-Myers SquibbINDUSTRY | 20 | Apr 14, 2011 | clinicaltrials |
| NCT00386685 | XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer | completed | Phase 2 | 51 | SanofiINDUSTRY | 4 | Apr 12, 2011 | clinicaltrials |
| NCT00578201 | FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer(FOLFOX) | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 31, 2011 | clinicaltrials |
| NCT00371254 | A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer | completed | Phase 2 | 55 | Bristol-Myers SquibbINDUSTRY | 4 | Mar 15, 2011 | clinicaltrials |
| NCT00774878 | Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer | terminated | Phase 2 | 18 | SanofiINDUSTRY | 3 | Mar 3, 2011 | clinicaltrials |
| NCT00006114 | Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Mar 1, 2011 | clinicaltrials |
| NCT00189566 | Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse | completed | Phase 2 | 165 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00231582 | High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II | completed | Phase 2 | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00270491 | Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. | completed | Phase 2 | 130 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00517621 | Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire | completed | Phase 2 | 100 | ARCAGY/ GINECO GROUPOTHER | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00372775 | Study Tests The Safety And Effectiveness Of SU011248 In Patients With Non-Small Cell Lung Cancer Having Brain Metastases | completed | Phase 2 | 66 | PfizerINDUSTRY | 4 | Feb 24, 2011 | clinicaltrials |
| NCT00224601 | CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 18, 2011 | clinicaltrials |
| NCT01168050 | Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.(NILOMEL) | unknown | Phase 2 | 25 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT00285103 | SPC2996 in Chronic Lymphocytic Leukaemia | completed | Phase 1 / Phase 2 | 46 | Santaris Pharma A/SINDUSTRY | 4 | Feb 2, 2011 | clinicaltrials |
| NCT00987987 | Amplifying Graft-Versus-Tumor Effect by Donor Regulatory T-Cell Depletion Before Donor Lymphocytes Infusion(ILD-Treg) | completed | Phase 1 / Phase 2 | 21 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00235937 | Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex | completed | Phase 2 | 45 | AstraZenecaINDUSTRY | 1 | Jan 21, 2011 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
| NCT00750126 | Allogeneic Hematopoietic Stem Cell Transplantation(RICE) | unknown | Phase 2 | 30 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT00751894 | Pegfilgrastim for Stem Cell Mobilization in Children (Meg-5)(MEG-5) | unknown | Phase 2 | 30 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT01007617 | Low-energy Laser Therapy for Prevention of Oral Mucositis in Children | unknown | Phase 2 / Phase 3 | 40 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT01156350 | Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma(Rice NK) | unknown | Phase 2 | 10 | University Hospital, Clermont-FerrandOTHER | 1 | Jan 19, 2011 | clinicaltrials |
| NCT00191984 | A Study of the Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer | completed | Phase 2 | 46 | Eli Lilly and CompanyINDUSTRY | 1 | Jan 5, 2011 | clinicaltrials |
| NCT00268892 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | completed | Phase 2 / Phase 3 | 278 | Ferring PharmaceuticalsINDUSTRY | 10 | Dec 24, 2010 | clinicaltrials |
| NCT01262417 | Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation(SEPRAC2T) | completed | Phase 2 | 60 | Centre Leon BerardOTHER | 1 | Dec 17, 2010 | clinicaltrials |
| NCT00116753 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | completed | Phase 2 | 460 | Ferring PharmaceuticalsINDUSTRY | 11 | Dec 10, 2010 | clinicaltrials |
| NCT00829192 | Phase II AK Study in Organ Transplant Patients | unknown | Phase 2 | 200 | Clinuvel Pharmaceuticals LimitedINDUSTRY | 7 | Dec 6, 2010 | clinicaltrials |
| NCT01242566 | Temozolomide in Elderly Patients With KPS < 70(TAG) | completed | Phase 2 | 70 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Nov 17, 2010 | clinicaltrials |
| NCT00136591 | A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell Lymphoma | terminated | Phase 2 | 87 | Lymphoma Study AssociationOTHER | 2 | Oct 26, 2010 | clinicaltrials |
| NCT00350792 | Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients | completed | Phase 2 | 62 | Eli Lilly and CompanyINDUSTRY | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00811759 | Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma | unknown | Phase 1 / Phase 2 | 58 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Oct 7, 2010 | clinicaltrials |
| NCT01182272 | Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery | unknown | Phase 2 | 36 | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00101816 | Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate | completed | Phase 2 | 124 | Bristol-Myers SquibbINDUSTRY | 20 | Aug 10, 2010 | clinicaltrials |
| NCT00103844 | Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 32 | Aug 10, 2010 | clinicaltrials |
| NCT00791544 | Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma | terminated | Phase 1 / Phase 2 | 13 | SanofiINDUSTRY | 1 | Aug 4, 2010 | clinicaltrials |
| NCT00794261 | Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma(PALM) | completed | Phase 2 | 150 | Centre Leon BerardOTHER | 1 | Jul 8, 2010 | clinicaltrials |
| NCT00647140 | Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer(DOPMET) | terminated | Phase 2 | 29 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 7, 2010 | clinicaltrials |
| NCT00006367 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis | completed | Phase 2 | — | Fred Hutchinson Cancer CenterOTHER | 3 | Jun 17, 2010 | clinicaltrials |
| NCT00221728 | Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors | terminated | Phase 2 / Phase 3 | 160 | University Hospital, BordeauxOTHER | 1 | May 28, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT00198393 | Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV | completed | Phase 2 | 126 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Apr 30, 2010 | clinicaltrials |
| NCT00298467 | MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma | withdrawn | Phase 2 | 45 | Bristol-Myers SquibbINDUSTRY | 2 | Apr 26, 2010 | clinicaltrials |
| NCT00371566 | A Study Of Lapatinib Versus Placebo Followed By Chemoradiation In Patients With Locally Advanced Head And Neck Cancer | completed | Phase 2 | 107 | GlaxoSmithKlineINDUSTRY | 5 | Apr 6, 2010 | clinicaltrials |
| NCT00099879 | Study of BMS-275183 in Patients With Pre-treated Non-small Cell Lung Cancer | terminated | Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 7 | Mar 2, 2010 | clinicaltrials |
| NCT00101608 | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium | completed | Phase 2 | 150 | Bristol-Myers SquibbINDUSTRY | 15 | Mar 2, 2010 | clinicaltrials |
| NCT00289640 | Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma | completed | Phase 2 | 210 | Bristol-Myers SquibbINDUSTRY | 10 | Mar 2, 2010 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials